Deepak Nitrite Ltd.
DEEPAKNTRCommodities filings
We hold this company’s filings and have not read the financial statements out of them yet. Every filing on record is listed under filings, and each one opens.
Earnings calls
18 transcript(s)/analyst meet(s) served; 2 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 18 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| TRANSCRIPT | 20220511 | 2022-03-31 | yes | |
| COVER_LETTER | 20221117 | 2022-09-30 | no | |
| COVER_LETTER | 20230215 | 2022-12-31 | no | |
| TRANSCRIPT | 20220817 | 2023-03-31 | yes | |
| TRANSCRIPT | 20230519 | 2023-03-31 | yes | |
| TRANSCRIPT | 20230816 | 2023-06-30 | yes | |
| TRANSCRIPT | 20231116 | 2023-09-30 | yes | |
| TRANSCRIPT | 20240221 | 2023-12-31 | yes | |
| TRANSCRIPT | 20240527 | 2024-03-31 | yes | |
| TRANSCRIPT | 20241121 | 2024-09-30 | yes | |
| TRANSCRIPT | 20250221 | 2024-12-31 | yes | |
| TRANSCRIPT | 20240813 | 2025-03-31 | yes | |
| TRANSCRIPT | 20250603 | 2025-03-31 | yes | |
| TRANSCRIPT | 20250821 | 2025-06-30 | yes | |
| TRANSCRIPT | 20251120 | 2025-09-30 | yes | |
| TRANSCRIPT | 20260218 | 2025-12-31 | yes | |
| TRANSCRIPT | 20260522 | 2026-03-31 | yes | |
| TRANSCRIPT | 20260811 | 2026-06-30 | yes |
DEEPAKNTR
files the standard Schedule III statements. Every figure below opens to the filing it was read from; where a figure is not shown, the reason is printed in its place.
Identity
| Statement division | general |
| Scope served | consolidated |
| Panels on this page | 4 |
Market
No split, bonus or consolidation is on record for this company inside the period this price series covers, so the closes need no adjustment.
| Last close | 1,600.90 |
| 52-week range | 1286.8 – 1875.9 |
| Return 1M | -8.57% |
| Return 3M | -1.33% |
| Return 1Y | -14.36% |
| Return 3Y | -25.13% |
| Return 5Y | -35.6% |
| Market capitalisation | not shown — we could not confirm it |
| Shares outstanding | not shown — we could not confirm it |
| P/E | not shown — we could not confirm it |
| P/B | not shown — we could not confirm it |
| EV/EBITDA | not shown — we could not confirm it |
Latest quarter filed — period ending 2026-06-30
In INR crore except per-share figures. `period_id` is the period the filing names for the number; the date beside each cell is when it was filed.
| Revenue from operations | 2,578.00 |
| Other income | 14.00 |
| Total income | 2,592.00 |
| Cost of materials consumed | 1,581.00 |
| Purchases of stock-in-trade | 61.00 |
| Changes in inventories | -14.00 |
| Employee benefit expense | 118.00 |
| Finance costs | 23.00 |
Ownership — 2026-06-30, and the change from 2026-03-31
| Holder | Per cent | Change |
|---|---|---|
| promoter and promoter group | 0.49 | 0.00 |
| institutions foreign | 0.06 | 0.00 |
| institutions domestic | 0.24 | 0.00 |
| mutual funds | 0.11 | 0.00 |
| public | 0.51 | -0.00 |
Documents on file
| Class | Most recent | On file |
|---|---|---|
| COVER_LETTER | 2022-12-31 | 2 |
| TRANSCRIPT | 2026-06-30 | 16 |
Financial statements
Filed results, consolidated, in INR crore except per-share figures. Every figure opens to the filing it was read from. Quarterly and annual columns are the periods the filing itself names, never a document date.
Quarterly results, as filed
| Line | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,962.00 | 1,991.00 | 1,961.00 | 1,768.00 | 1,778.00 | 2,009.00 | 2,126.00 | 2,167.00 | 2,032.00 | 1,903.00 | 2,180.00 | 1,890.00 | 1,902.00 | 1,975.00 | 2,120.00 | 2,578.00 |
| Other income | 12.00 | 13.00 | 13.00 | 32.00 | 17.00 | 14.00 | 19.00 | 19.00 | 21.00 | 21.00 | 23.00 | 25.00 | 20.00 | 8.00 | 7.00 | 14.00 |
| Total income | 1,974.00 | 2,004.00 | 1,974.00 | 1,800.00 | 1,795.00 | 2,023.00 | 2,145.00 | 2,186.00 | 2,053.00 | 1,924.00 | 2,202.00 | 1,914.00 | 1,922.00 | 1,983.00 | 2,127.00 | 2,592.00 |
| Cost of materials consumed | 1,448.00 | 1,268.00 | 1,251.00 | 1,090.00 | 1,093.00 | 1,459.00 | 1,414.00 | 1,413.00 | 1,456.00 | 1,333.00 | 1,479.00 | 1,331.00 | 1,244.00 | 1,372.00 | 1,378.00 | 1,581.00 |
| Purchases of stock-in-trade | 0.00 | 16.00 | 122.00 | 45.00 | 31.00 | 0.00 | 2.00 | 23.00 | 77.00 | 14.00 | 18.00 | 64.00 | 76.00 | 75.00 | 59.00 | 61.00 |
| Changes in inventories | -78.00 | 55.00 | -95.00 | 89.00 | 42.00 | -87.00 | 58.00 | 65.00 | -151.00 | 47.00 | 15.00 | -34.00 | 58.00 | -21.00 | -57.00 | -14.00 |
| Employee benefit expense | 79.00 | 81.00 | 77.00 | 84.00 | 85.00 | 89.00 | 93.00 | 95.00 | 97.00 | 98.00 | 102.00 | 106.00 | 99.00 | 107.00 | 111.00 | 118.00 |
| Finance costs | 6.00 | 6.00 | 4.00 | 2.00 | 3.00 | 3.00 | 4.00 | 6.00 | 6.00 | 6.00 | 9.00 | 8.00 | 8.00 | 11.00 | 19.00 | 23.00 |
| Depreciation and amortisation | 42.00 | 41.00 | 41.00 | 38.00 | 39.00 | 42.00 | 46.00 | 47.00 | 48.00 | 48.00 | 51.00 | 51.00 | 53.00 | 58.00 | 63.00 | 64.00 |
| Other expenses | 242.00 | 257.00 | 258.00 | 251.00 | 225.00 | 243.00 | 258.00 | 262.00 | 255.00 | 244.00 | 249.00 | 233.00 | 221.00 | 232.00 | 254.00 | 291.00 |
| Total expenses | 1,739.00 | 1,723.00 | 1,659.00 | 1,598.00 | 1,518.00 | 1,749.00 | 1,876.00 | 1,911.00 | 1,789.00 | 1,789.00 | 1,924.00 | 1,760.00 | 1,759.00 | 1,833.00 | 1,826.00 | 2,124.00 |
| Profit before exceptional items and tax | 235.00 | 281.00 | 315.00 | 202.00 | 277.00 | 274.00 | 269.00 | 275.00 | 264.00 | 135.00 | 279.00 | 155.00 | 163.00 | 151.00 | 301.00 | 468.00 |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 80.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -13.00 | 0.00 | 0.00 |
| Profit before tax | 235.00 | 281.00 | 315.00 | 202.00 | 277.00 | 274.00 | 349.00 | 275.00 | 264.00 | 135.00 | 279.00 | 155.00 | 163.00 | 138.00 | 301.00 | 468.00 |
| Current tax | 57.00 | 65.00 | 59.00 | 51.00 | 69.00 | 70.00 | 84.00 | 74.00 | 71.00 | 37.00 | 46.00 | 42.00 | 42.00 | 41.00 | 66.00 | 130.00 |
| Deferred tax | 3.00 | 7.00 | 23.00 | 1.00 | 4.00 | 2.00 | 11.00 | -2.00 | -1.00 | 0.00 | 30.00 | 1.00 | 2.00 | -3.00 | 16.00 | -8.00 |
| Tax expense | 60.00 | 72.00 | 81.00 | 52.00 | 72.00 | 72.00 | 95.00 | 72.00 | 70.00 | 37.00 | 76.00 | 42.00 | 44.00 | 38.00 | 82.00 | 123.00 |
| Profit for the period | 174.00 | 209.00 | 234.00 | 150.00 | 205.00 | 202.00 | 254.00 | 203.00 | 194.00 | 98.00 | 202.00 | 112.00 | 119.00 | 100.00 | 220.00 | 345.00 |
| Profit attributable to owners | 174.00 | 209.00 | 234.00 | 150.00 | 205.00 | 202.00 | 253.00 | 203.00 | 194.00 | 98.00 | 202.00 | 112.00 | 119.00 | 100.00 | 220.00 | 345.00 |
| Profit attributable to non-controlling interests | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Other comprehensive income | -0.00 | -1.00 | -4.00 | -0.00 | -0.00 | -1.00 | -1.00 | -0.00 | -1.00 | -1.00 | -2.00 | -1.00 | -3.00 | 1.00 | -2.00 | -0.00 |
| Total comprehensive income | 174.00 | 208.00 | 230.00 | 150.00 | 205.00 | 202.00 | 253.00 | 202.00 | 194.00 | 97.00 | 201.00 | 112.00 | 116.00 | 101.00 | 218.00 | 345.00 |
| Earnings per share, basic | 12.79 | 15.33 | 17.15 | 10.99 | 15.04 | 14.81 | 18.61 | 14.85 | 14.24 | 7.19 | 14.84 | 8.23 | 8.71 | 7.32 | 16.11 | 25.30 |
| Earnings per share, diluted | 12.79 | 15.33 | 17.15 | 10.99 | 15.04 | 14.81 | 18.61 | 14.85 | 14.24 | 7.19 | 14.84 | 8.23 | 8.71 | 7.32 | 16.11 | 25.30 |
Annual results, as filed
| Line | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,792.00 | 4,230.00 | 4,360.00 | 6,802.00 | 7,972.00 | 7,682.00 | 8,282.00 | 7,887.00 |
| Other income | 3.00 | 35.00 | 22.00 | 43.00 | 48.00 | 76.00 | 84.00 | 60.00 |
| Total income | 1,795.00 | 4,265.00 | 4,381.00 | 6,845.00 | 8,020.00 | 7,758.00 | 8,366.00 | 7,947.00 |
| Cost of materials consumed | 1,028.00 | 2,348.00 | 2,274.00 | 4,211.00 | 5,395.00 | 5,056.00 | 5,681.00 | 5,324.00 |
| Purchases of stock-in-trade | 0.00 | 0.00 | 0.00 | 0.00 | 144.00 | 77.00 | 132.00 | 274.00 |
| Changes in inventories | -52.00 | 26.00 | -10.00 | -97.00 | -191.00 | 103.00 | -25.00 | -55.00 |
| Employee benefit expense | 159.00 | 219.00 | 247.00 | 274.00 | 318.00 | 351.00 | 392.00 | 423.00 |
| Finance costs | 43.00 | 115.00 | 74.00 | 34.00 | 25.00 | 12.00 | 28.00 | 46.00 |
| Depreciation and amortisation | 53.00 | 140.00 | 153.00 | 178.00 | 166.00 | 166.00 | 195.00 | 225.00 |
| Other expenses | 352.00 | 612.00 | 601.00 | 810.00 | 1,017.00 | 971.00 | 1,010.00 | 940.00 |
| Total expenses | 1,582.00 | 3,459.00 | 3,340.00 | 5,410.00 | 6,874.00 | 6,736.00 | 7,413.00 | 7,177.00 |
| Profit before exceptional items and tax | 212.00 | 806.00 | 1,042.00 | 1,434.00 | 1,146.00 | 1,022.00 | 953.00 | 770.00 |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 80.00 | 0.00 | -13.00 |
| Profit before tax | 212.00 | 806.00 | 1,042.00 | 1,434.00 | 1,146.00 | 1,102.00 | 953.00 | 757.00 |
| Current tax | 49.00 | 192.00 | 240.00 | 353.00 | 259.00 | 273.00 | 228.00 | 191.00 |
| Deferred tax | 26.00 | 3.00 | 26.00 | 15.00 | 35.00 | 18.00 | 27.00 | 16.00 |
| Tax expense | 74.00 | 195.00 | 266.00 | 368.00 | 294.00 | 291.00 | 255.00 | 206.00 |
| Profit for the period | 138.00 | 611.00 | 776.00 | 1,067.00 | 852.00 | 811.00 | 697.00 | 551.00 |
| Profit attributable to owners | — | 607.00 | 776.00 | 1,067.00 | 852.00 | 809.00 | 697.00 | 551.00 |
| Profit attributable to non-controlling interests | — | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 |
| Other comprehensive income | -3.00 | -4.00 | -1.00 | 0.00 | -5.00 | -2.00 | -3.00 | -4.00 |
| Total comprehensive income | 135.00 | 607.00 | 775.00 | 1,067.00 | 847.00 | 809.00 | 694.00 | 547.00 |
| Earnings per share, basic | 10.12 | 44.80 | 56.88 | 78.20 | 62.47 | 59.45 | 51.12 | 40.36 |
| Earnings per share, diluted | 10.12 | 44.80 | 56.88 | 78.20 | 62.47 | 59.45 | 51.12 | 40.36 |
Balance sheet, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 4,669.00 | 5,129.00 | 5,268.00 | 6,096.00 | 7,009.00 | 7,718.00 | 7,884.00 | 8,681.00 |
| Non-current assets | 2,219.00 | 2,390.00 | 2,692.00 | 3,255.00 | 3,819.00 | 4,421.00 | 5,082.00 | 5,611.00 |
| Current assets | 2,449.00 | 2,739.00 | 2,576.00 | 2,842.00 | 3,189.00 | 3,297.00 | 2,801.00 | 3,069.00 |
| Property, plant and equipment | 1,887.00 | 1,914.00 | 1,946.00 | 2,243.00 | 2,346.00 | 2,400.00 | 2,512.00 | 3,210.00 |
| Capital work-in-progress | 181.00 | 283.00 | 479.00 | 774.00 | 1,169.00 | 1,649.00 | 2,046.00 | 1,828.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Other intangible assets | 30.00 | 28.00 | 26.00 | 50.00 | 55.00 | 54.00 | 52.00 | 57.00 |
| Inventories | 740.00 | 893.00 | 726.00 | 760.00 | 916.00 | 926.00 | 904.00 | 862.00 |
| Trade receivables | 1,096.00 | 1,310.00 | 1,212.00 | 1,298.00 | 1,254.00 | 1,274.00 | 1,381.00 | 1,506.00 |
| Cash and cash equivalents | 63.00 | 38.00 | 15.00 | 238.00 | 33.00 | 179.00 | 22.00 | 243.00 |
| Total equity and liabilities | 4,669.00 | 5,129.00 | 5,268.00 | 6,096.00 | 7,009.00 | 7,718.00 | 7,884.00 | 8,681.00 |
| Equity | 3,651.00 | 4,090.00 | 4,342.00 | 4,823.00 | 5,125.00 | 5,425.00 | 5,550.00 | 5,869.00 |
| Equity share capital | 27.00 | 27.00 | 27.00 | 27.00 | 27.00 | 27.00 | 27.00 | 27.00 |
| Other equity | 3,624.00 | 4,063.00 | 4,315.00 | 4,769.00 | 5,061.00 | 5,361.00 | 5,488.00 | 5,810.00 |
| Total liabilities | 1,018.00 | 1,039.00 | 926.00 | 1,274.00 | 1,884.00 | 2,293.00 | 2,333.00 | 2,811.00 |
| Non-current liabilities | 261.00 | 245.00 | 238.00 | 488.00 | 1,046.00 | 1,370.00 | 1,446.00 | 1,533.00 |
| Current liabilities | 756.00 | 794.00 | 688.00 | 785.00 | 839.00 | 923.00 | 887.00 | 1,279.00 |
| Borrowings, non-current | 95.00 | 43.00 | 40.00 | 217.00 | 772.00 | 1,026.00 | 1,089.00 | 1,135.00 |
| Borrowings, current | 159.00 | 11.00 | 13.00 | 0.00 | 19.00 | 145.00 | 60.00 | 393.00 |
| Trade payables | 500.00 | 662.00 | 512.00 | 582.00 | 557.00 | 522.00 | 556.00 | 534.00 |
Cash flow, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | 302.00 | 650.00 | 535.00 | 878.00 | 324.00 | 625.00 | 204.00 | 539.00 |
| Net cash from investing activities | -119.00 | -276.00 | -427.00 | -722.00 | -973.00 | -1,491.00 | -215.00 | -669.00 |
| Net cash from financing activities | -144.00 | -359.00 | -130.00 | 44.00 | 442.00 | 806.00 | -146.00 | 193.00 |
| Purchase of property, plant and equipment | 143.00 | 358.00 | 305.00 | 742.00 | 477.00 | 1,122.00 | 662.00 | 1,185.00 |
| Net increase in cash | 40.00 | 15.00 | -23.00 | 200.00 | -207.00 | -60.00 | -157.00 | 64.00 |
| con:CFO.BEFORE_TAX | 437.00 | 910.00 | 645.00 | 1,144.00 | 444.00 | 840.00 | 286.00 | 728.00 |
| con:INTEREST_RECEIVED.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INTEREST_PAID.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:DIVIDENDS_RECEIVED.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:TAX_PAID.OPERATING | 135.00 | 260.00 | 110.00 | 266.00 | 120.00 | 215.00 | 82.00 | 189.00 |
| con:CF_OTHER.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INVESTMENTS_PURCHASED | 0.00 | 0.00 | 17.00 | 0.00 | 0.00 | 364.00 | 0.00 | 14.00 |
| con:INVESTMENTS_SOLD | 24.00 | 82.00 | -107.00 | 289.00 | -255.00 | 0.00 | 218.00 | 329.00 |
| con:PPE_DISPOSALS | 0.00 | 1.00 | 0.00 | 3.00 | 0.00 | 17.00 | 0.00 | 2.00 |
| con:CF_INVESTING.SUBSIDIARIES_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.SUBSIDIARIES_ACQUIRED | 0.00 | 0.00 | 0.00 | 27.00 | 42.00 | 42.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_ACQUIRED | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Who owns it
The shareholding pattern filed with the exchange every quarter, as a series. Percentages are of total shares. Each figure names the filing it was read from and the date it was filed.
| Holder | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter and promoter group | 49.13 | 49.13 | 49.13 | 49.13 | 49.13 | 49.24 | 49.24 | 49.24 | 49.28 | 49.28 | 0.49 | 0.49 | 0.49 | 0.49 |
| Domestic institutions | 15.05 | 15.62 | 17.95 | 18.87 | 19.27 | 21.21 | 22.29 | 23.22 | 23.22 | 22.62 | 0.23 | 0.23 | 0.23 | 0.24 |
| Mutual funds | — | — | — | — | — | — | — | — | — | 11.68 | 0.11 | 0.11 | 0.11 | 0.11 |
| Insurance companies | 7.01 | 6.98 | 8.46 | 9.30 | 9.42 | 9.96 | 10.06 | 9.95 | 10.03 | 9.93 | 0.10 | 0.10 | 0.11 | 0.10 |
| Foreign institutions | 7.72 | 8.08 | 6.47 | 6.48 | 6.72 | 6.86 | 6.69 | 6.60 | 6.65 | 6.68 | 0.06 | 0.06 | 0.06 | 0.06 |
| Government | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.00 |
| Public | 50.87 | 50.87 | 50.87 | 50.87 | 50.87 | 50.76 | 50.76 | 50.76 | 50.72 | 50.72 | 0.51 | 0.51 | 0.51 | 0.51 |
| Non-institutional | 28.09 | 27.17 | 26.44 | 25.52 | 24.87 | 22.69 | 21.78 | 20.94 | 20.85 | 21.42 | 0.22 | 0.21 | 0.21 | 0.21 |
| Shares outstanding | 136393041 | 136393041 | 136393041 | 136393041 | 136393041 | 136393041 | 136393041 | 136393041 | 136393041 | 136393041 | 136393041 | 136393041 | 136393041 | 136393041 |
Related parties
Transactions with related parties as disclosed to the exchange for the period ending 2024-09-30, by counterparty, largest first. Amounts are as filed. Each row names the filing and the date it was filed.
| Counterparty | Relationship | Type | Amount in the period | Transactions |
|---|---|---|---|---|
| Shri Deepak C Mehta | Key Management Personnel of Subsid | Any other transaction, Interest paid, Remuneration | 313,500,000.00 | 3 |
| Deepak Fertilisers & Petrochemicals Corporation Limited | Entities over which key managerial | Any other transaction, Purchase of goods or services | 289,800,000.00 | 2 |
| Performance Chemiserve Limited | Entities over which key managerial | Purchase of goods or services | 198,900,000.00 | 1 |
| Deepak Novochem Technologies Limited | Entities over which key managerial | Any other transaction, Sale of goods or services | 118,600,000.00 | 2 |
| Smt. Ila D. Mehta | Relative of KMP | Any other transaction, Interest paid | 52,900,000.00 | 3 |
| Shri Deepak C. Mehta | Key Management Personnel | Remuneration | 40,500,000.00 | 1 |
| Shri Sanjay B Upadhyay | Key Management Personnel | Remuneration | 28,900,000.00 | 1 |
| Shri Maulik.D. Mehta | Key Management Personnel | Remuneration | 23,100,000.00 | 1 |
| Shri Kishor Jhalaria | Key Management Personnel of Subsid | Remuneration | 18,800,000.00 | 1 |
| Hyspec Chemicals Private Limited | Entities over which key managerial | Any other transaction, Sale of goods or services | 14,800,000.00 | 3 |
| Shri Girish Satarkar | Key Management Personnel | Remuneration | 11,700,000.00 | 1 |
| OXOC Chemicals Limited | Entities over which key managerial | Purchase of goods or services | 11,100,000.00 | 1 |
| Shri Ajay Jajoo | Key Management Personnel of Subsid | Remuneration | 10,500,000.00 | 1 |
| Shri Somsekhar A. Nanda | Key Management Personnel | Remuneration | 9,900,000.00 | 1 |
| Deepak Cybit Private Limited | Entities over which key managerial | Any other transaction, Purchase of goods or services | 8,900,000.00 | 3 |
What management said
Every earnings call we hold for this company, read in full. Prepared remarks are separated from the question-and-answer session and every paragraph names who said it and on which page. These are management’s own words, not filed figures.
| Date | Quarter | Who spoke | |
|---|---|---|---|
| 2026-08-11 | Q1FY27 | Read the call | |
| 2026-05-22 | Q4FY26 | Read the call | |
| 2026-02-18 | Q3FY26 | Read the call | |
| 2025-11-20 | Q2FY26 | Read the call | |
| 2025-08-21 | Q1FY26 | Read the call | |
| 2025-06-03 | FYFY25 | Read the call | |
| 2025-02-21 | Q3FY25 | Read the call | |
| 2024-11-21 | H1FY25 | Read the call | |
| 2024-08-13 | FYFY25 | EXECUTIVE OFFICER, GROUP CFO | Read the call |
| 2024-05-27 | FYFY24 | Read the call | |
| 2024-02-21 | Q3FY24 | Read the call | |
| 2023-11-16 | H1FY24 | Read the call | |
| 2023-08-16 | Q1FY24 | LIMITED | Read the call |
| 2023-05-19 | Q4FY23 | ANALYST: | Read the call |
| 2022-08-17 | FYFY23 | Read the call | |
| 2022-05-11 | FYFY22 | DEPUTY, LIMITED, SOMSEKHAR | Read the call |
Some earlier announcements under this heading are covering letters only — no transcript was attached.
What they said about it, quarter by quarter
| Topic | Q1FY26 | Q1FY27 | Q2FY26 | Q3FY24 | Q3FY25 | Q3FY26 | Q4FY23 | Q4FY26 |
|---|---|---|---|---|---|---|---|---|
| Capex | If I recall it correctly, we are undergoing INR 8,500 crore of capex plus INR 2,000 crore of capex, which is under various stages of commissioning. | How much capex is pending, which will be spent this year? | And generally, all of this is around with, I would say, either 0 or insignificant CAPEX. | We have also initiated land for large scale capex which should be Greenfield for example, Oman plant. | So now we are in the advanced process of commissioning it by end of Q4 FY25, if you can share how much of the capex we have incurred on the same. | So, other than the last one, which I mentioned, which is polymer applications, which requires medium-sized CAPEX. | Sir just one last clarification in our presentation you had mentioned that there are Rs.2,500 crore projects currently which are undergoing so what is… | So Deepak Nitrite Limited May 18, 2026 our capex includes the ability to have this in a slightly disjointed manner. |
| Capital allocation | — | All of these will allow us to also participate in the merchant market as the downstream capacities get ramped up and the customer acquisition is in li… | — | — | — | — | — | — |
| Costs | So you change the raw materials from A to B, you're able to make a product which goes into a different application. | Within AI, pressure of high- cost raw materials remained for certain products. | One, we do have an alignment similar to the way that we have with regards to other key raw materials, which allow us to import ammonia as well as buy … | And keep in mind that we also in many cases have to take up the cost of logistics of getting the raw material, as well as in some cases giving the fin… | And in those places when we buy our raw materials, those raw materials also come with an N -1 or N -2 in terms of the prices. | And also if you can share your thoughts, are we importing any raw materials currently from Europe, which earlier used to have a duty and with this EU … | So because you rightly said that turnover is difficult to predict because it all depends upon the selling prices of the products, but if we see FY2020… | But just wanted to understand on the raw material availability that is propylene, how much of our capacity right now are we running? |
| Debt and cash | — | So today, at this INR 11,500 crore what we are having against that, we are borrowing around INR 6,800 crore plus working capital, whatever is required… | — | It would be a considerable amount, but what I was sharing was largely the situation that was at play into Q3, agrochemicals especially the products th… | So, you are saying that there has been an element of operating deleverage as well? | — | — | So in all of these cases, all I can say is that having a domestic supplier of high-quality products is a game changer for domestic consumers who don't… |
| Demand | First on the agrochemical side, can you help us understand what really has happened, it is lower demand, because destocking appears to be largely behi… | While the chemical industry at large continues to navigate price volatility, evolving geopolitical dynamics and an uneven demand recovery, we believe … | So now we have multiple storage facilities that are all feeding into our consumption point where pipelines. | This year we have demonstrated that one of the plants we have spent little amount and then produce additional product which was never there in our bud… | However, other than that also, in a couple of our assets where we had plant capacities available, those assets were idled until the customer demand pi… | At the moment, we have a pipeline of about 15 products at various stages between R&D, piloting and awaiting customer feedback with regards to samples. | Could you give some color on the demand trends that you have been witnessing for your key end segments in the month of April and May? | And (b), given the kind of raw materials what we use for the standalone business like ortho-xylene, ammonia, sulfuric acid, AHF, how have we secured i… |
| Guidance | So just on nitric acid, should we expect the benefits to start from the second quarter of this financial year? | This provides us with greater confidence in the medium-term outlook for the business. | And overall, if you can guide what will be the FY26 volume growth on the phenol front? | So, two parts of question on this, whether the inventory destocking by the Chinese players is over and can we expect the things getting normalizing in… | Though January and February were affected by imports this year, we expect a normalized situation from March onwards. | When can we expect the full benefit of nitric acid into our operational numbers? | Sir I have two questions so one is when we see our performance in FY2020, vis-à-vis what we have delivered in FY2023 for the standalone business, I th… | When can we expect that or do you think this is not the right time to start a new plant and probably you would wait for another quarter to see how the… |
| Margin | Some of them which would be higher margin have had a deferment of supply from our customers, which we are working to see how to address. | More importantly, the investments we have made over the past several years are now beginning to translate into stronger operating leverage and improve… | So we're looking at significantly increasing our own self-consumption because that's where we will make more margin. | What's a fair assessment in terms of our quarterly EBITDA again moving to those ranges of Rs. | 53 crore, but the EBITDA impact was close to Rs. | I got a few questions, Maulik bhai, First, regarding the standalone business: for at least part of this quarter, nitric acid and the gross profit marg… | Nonetheless, we have been able to maintain a reasonably healthy margin on a per kilo basis and as we expand, in FY2021, we had a plant which was about… | Did we achieve the margin profile we were looking at? |
| People | So realistically, what sort of capacity utilization percentages could we work with for this financial year and then maybe next financial year? | And we have already started operating these assets with a relatively high utilization, anticipating that we need to place our products in the market o… | So sir, here, like in terms of this Nitric Acid plant and capacities, would it be fair to assume that initially as our requirement picks up over the s… | And along with if you can just share your thoughts on how much of our current capacity like including those debottleneck is currently utilized and has… | Any comment on the utilization rates in some of these geographies? | First on the projects that we have started in this quarter, can we broadly give a direction to reach steady state, say, 80% to 100% utilization, how m… | Sir the second question is on like one of our competitor is also expanding on the NT side so how we are placed in terms of our existing utilization he… | First, on the nitric acid, can you just help us understand in this quarter, what was the utilization? |
| Pricing | In terms of current pricing, what is the optimal level of revenues that we are expecting? | While geopolitical developments and pricing volatility may continue to influence the operating environment, Deepak today is significantly stronger, si… | — | This gives us the delta of about a month, month, and a half, where we have that breathing room and it gives us the opportunity to optimize our pricing… | First of all, the import was not at an aggressive pricing or decremental pricing which happened right, during the quarter, that's the first question, … | What percentage of this would be purely led by the pricing, if you can give the pricing and volume decline or a growth, some broad directions on this. | The presentation mentions that there is contracted supply of products from both the segments which provides high visibility for continued growth so ju… | Have we passed on the entire pricing increase which has been witnessed in the market? |
| Revenue growth | So it should be looked at Deepak Nitrite Limited August 14, 2025 in line with that, that all the investment when you look at a backward integration do… | Lastly, is it possible to quantify in terms of what sort of incremental contribution in terms of, let's say, the top line as well as some flavor on th… | As I mentioned, key chemicals being absent from our Q2 sales plan has been a significant contributing factor to the top line as well as the bottom lin… | I can just share that we have already announced by and large every quarter there will be some plant, or another being commissioned, some with upstream… | So firstly on the Phenolics business, if we have lost around say 12,000 to 15,000 tonnes kind of volumes, how have we been able to maintain the kind o… | And second is, broadly in the last three years in the AI segment, the topline has reduced from, say, INR 3,000 crore, right now, we are close to aroun… | How this results with regards to topline growth is difficult to Deepak Nitrite Limited May 12, 2023 say because the market continues to be volatile. | — |